ORAL SINGLE- AND REPEATED-DOSE TOXICITY STUDIES ON GERANTI BIO-GE YEAST®, ORGANIC GERMANIUM FORTIFIED YEASTS, IN DOGS
- 1 January 2004
- journal article
- research article
- Published by Japanese Society of Toxicology in The Journal of Toxicological Sciences
- Vol. 29 (5), 555-569
- https://doi.org/10.2131/jts.29.555
Abstract
Single- and 13-week repeated-dose toxicities of Geranti Bio-Ge Yeast, organic germanium fortified yeasts, were investigated in dogs. Both sexes of Beagle dogs were orally administered once at a dose of 2,000 mg/kg in single-dose toxicity or daily for 13 weeks at doses of 500, 1,000 or 2,000 mg/kg in repeated-dose toxicity tests. In single-dose toxicity test, no animal dead, moribund, or showing clinical signs or changes in body weight gain was found. In repeated-dose toxicity study, there were no considerable changes in ophthalmoscopy and urinalysis. Several alterations were observed in electrocardiography, hematology and blood biochemistry, including heart rate, R-R interval, QT correcting, reticulocytes, activated partial thromboplastin time and albumin/globulin ratio in only male dogs, but not in females, administered with Geranti Bio-Ge Yeast in a dose-independent manner. In gross findings, several cases of abnormal findings were observed in both control and treatment groups, showing diffuse dark brown to black discoloration of liver, in a dose-independent manner. In microscopic examination, mild lesions, including cholestasis and inflammatory cell foci in liver, kidneys and prostate, were found sporadically in both control and treatment groups. In spite of some alterations in electrocardiography, hematology, blood biochemistry, gross and microscopic findings, such effects were not considered to include toxicopathological significance, based on the marginal changes within normal ranges and lack of dose-dependency, consistent time-course and gender relationship. Taken together, it is suggested that no observed adverse effect level (NOAEL) of Geranti Bio-Ge Yeast is considered to be 2,000 mg/kg in dogs, and that long-term treatment in clinical trials might not exert adverse effects.Keywords
This publication has 30 references indexed in Scilit:
- Effects of germanium oxide and other chemical compounds on phenylmercury acetate-induced genotoxicity in cultured human lymphocytesEnvironmental and Molecular Mutagenesis, 1998
- 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cellsCellular and Molecular Life Sciences, 1996
- Subchronic oral toxicity (six months) of carboxyethylgermanium sesquioxide [(HOOCCH2CH2Ge)2O3]n in ratsApplied Organometallic Chemistry, 1992
- Abuse of Germanium Associated with Fatal Lactic AcidosisNephron, 1992
- Chronic tubulointerstitial changes induced by germanium dioxide in comparison with carboxyethylgermanium sesquioxideKidney International, 1991
- Dangers of dietary germanium supplementsThe Lancet, 1990
- Effect of germanium on 1, 2-dimethylhydrazine-induced intestinal cancer in ratsDiseases of the Colon & Rectum, 1990
- Therapeutic effects of organic GermaniumMedical Hypotheses, 1988
- Antimutagenic effects of germanium oxide on Trp-P-2-induced frameshift mutations in Salmonella typhimurium TA98 and TA1538Mutation Research, 1984
- Antimicrobial Activity of Organogermanium DerivativesNature, 1964